We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Eliminating Pelvic Imaging Will Reduce Radiation Dose for Detecting Venous Thromboembolism

By MedImaging International staff writers
Posted on 18 May 2011
Pelvic imaging using computed tomography (CT) scans are not necessary for diagnosing patients with venous thromboembolism (VTE) and eliminating this exam can considerably reduce a patient's exposure to excessive radiation dose.

CT venography of the pelvis during CT pulmonary angiography does not improve the detection of VTE, according to Dr. Charbel Ishak, lead author for this study. He explained, "Using CT venography in the lower extremities without including the pelvis can decrease the population's radiation dose generated by CT usage."

In a retrospective review of 1,527 patients at the Nassau University Medical Center (East Meadow, NY,USA) during a three-year period, only 0.3% (5 of 1,527) of patients presented with isolated pelvic VTE after pulmonary embolism was ruled out of the CT protocol.

Dr. Ishak believes that these findings are promising for helping radiologists implement new protocols for pelvic examination and reducing additional radiation in patients. He stated, "Radiologists and technologists can eliminate pelvic imaging while acquiring only images of the lower extremities with CT venography, starting from groin to below the knee. We believe that by stopping the imaging of the pelvis, we can decrease patient radiation dose without significantly affecting the diagnosis of VTE."

Dr. Ishak delivered a presentation on this study on May 3, 2011, at the 2011 American Roentgen Ray Society (ARRS) annual meeting in Chicago (IL, USA).

Related Links:

Nassau University Medical Center



Computed Tomography System
Aquilion ONE / INSIGHT Edition
Mammo DR Retrofit Solution
DR Retrofit Mammography
High-Precision QA Tool
DEXA Phantom
Biopsy Software
Affirm® Contrast

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.